Search Results - "Kuijper, Ed"

Refine Results
  1. 1

    Understanding Clostridium difficile Colonization by Crobach, Monique J T, Vernon, Jonathan J, Loo, Vivian G, Kong, Ling Yuan, Péchiné, Séverine, Wilcox, Mark H, Kuijper, Ed J

    Published in Clinical microbiology reviews (01-04-2018)
    “…is the main causative agent of antibiotic-associated and health care-associated infective diarrhea. Recently, there has been growing interest in alternative…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Clostridium difficile infection: review by Czepiel, Jacek, Dróżdż, Mirosław, Pituch, Hanna, Kuijper, Ed J., Perucki, William, Mielimonka, Aleksandra, Goldman, Sarah, Wultańska, Dorota, Garlicki, Aleksander, Biesiada, Grażyna

    “…Clostridium difficile ( C. difficile ) is a Gram-positive, spore-forming, anaerobic bacillus, which is widely distributed in the intestinal tract of humans and…”
    Get full text
    Journal Article
  4. 4

    Issues and current standards of controls in microbiome research by Hornung, Bastian V H, Zwittink, Romy D, Kuijper, Ed J

    Published in FEMS microbiology ecology (01-05-2019)
    “…Good scientific practice is important in all areas of science. In recent years this has gained more and more attention, especially considering the 'scientific…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens by van Eijk, Erika, Wittekoek, Bert, Kuijper, Ed J, Smits, Wiep Klaas

    Published in Journal of antimicrobial chemotherapy (01-05-2017)
    “…With the impending crisis of antimicrobial resistance, there is an urgent need to develop novel antimicrobials to combat difficult infections and MDR…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Clostridium difficile infection by Smits, Wiep Klaas, Lyras, Dena, Lacy, D. Borden, Wilcox, Mark H., Kuijper, Ed J.

    Published in Nature reviews. Disease primers (07-04-2016)
    “…Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life threatening, especially in elderly people and in patients who…”
    Get full text
    Journal Article
  12. 12

    Clostridium difficile infection in Europe: a hospital-based survey by Bauer, Martijn P, Dr, Notermans, Daan W, PhD, van Benthem, Birgit HB, PhD, Brazier, Jon S, PhD, Wilcox, Mark H, Prof, Rupnik, Maja, Prof, Monnet, Dominique L, PhD, van Dissel, Jaap T, Prof, Kuijper, Ed J, PhD

    Published in The Lancet (British edition) (2011)
    “…Summary Background Little is known about the extent of Clostridium difficile infection in Europe. Our aim was to obtain a more complete overview of C difficile…”
    Get full text
    Journal Article
  13. 13

    Community-onset Clostridioides difficile infection in south Serbia by Stojanovic, Predrag, Harmanus, Celine, Kuijper, Ed J.

    Published in Anaerobe (01-02-2023)
    “…Data from the past decade indicates that Clostridioides difficile infection (CDI) is not only a nosocomial infection but is also increasingly recognized as a…”
    Get full text
    Journal Article
  14. 14

    Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view? by Krutova, Marcela, Wilcox, Mark, Kuijper, Ed

    “…•Oral administration of metronidazole results in low concentration in stool.•A low concentration of metronidazole prolongs Clostridioides difficile…”
    Get full text
    Journal Article
  15. 15

    High-Throughput Identification of Bacteria and Yeast by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Conventional Medical Microbiology Laboratories by van Veen, S.Q, Claas, E.C.J, Kuijper, Ed J

    Published in Journal of Clinical Microbiology (01-03-2010)
    “…Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) is suitable for high-throughput and rapid diagnostics at low costs…”
    Get full text
    Journal Article
  16. 16

    TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm by Bakker, Dennis, Smits, Wiep Klaas, Kuijper, Ed J, Corver, Jeroen

    Published in PloS one (17-08-2012)
    “…In the past decade, Clostridium difficile has emerged as an important gut pathogen. Symptoms of C. difficile infection range from mild diarrhea to…”
    Get full text
    Journal Article
  17. 17

    Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics by Hensgens, Marjolein P. M., Goorhuis, Abraham, Dekkers, Olaf M., Kuijper, Ed J.

    Published in Journal of antimicrobial chemotherapy (01-03-2012)
    “…Background Clostridium difficile infections (CDIs) are common in developed countries and affect >250 000 hospitalized patients annually in the USA. The most…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Plasmid-mediated metronidazole resistance in Clostridioides difficile by Boekhoud, Ilse M., Hornung, Bastian V. H., Sevilla, Eloisa, Harmanus, Céline, Bos-Sanders, Ingrid M. J. G., Terveer, Elisabeth M., Bolea, Rosa, Corver, Jeroen, Kuijper, Ed J., Smits, Wiep Klaas

    Published in Nature communications (30-01-2020)
    “…Metronidazole was until recently used as a first-line treatment for potentially life-threatening Clostridioides difficile (CD) infection. Although cases of…”
    Get full text
    Journal Article
  20. 20

    Emergence of Clostridium difficile Infection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078 by Goorhuis, Abraham, Bakker, Dennis, Corver, Jeroen, Debast, Sylvia B., Harmanus, Celine, Notermans, Daan W., Bergwerff, Aldert A., Dekker, Frido W., Kuijper, Ed J.

    Published in Clinical infectious diseases (01-11-2008)
    “…Background. Since 2005, an increase in the prevalence of Clostridium difficile infection (CDI) due to polymerase chain reaction ribotype 078 has been noticed…”
    Get full text
    Journal Article